Európska únia - slovenčina - EMA (European Medicines Agency)

recordati rare diseases - kyselina karglumová - amino acid metabolism, inborn errors; propionic acidemia - iné alimentárny trakt a metabolizmus výrobky, - carbaglu je indikovaný v liečbe:hyperammonaemia vzhľadom na n-acetylglutamate-synthase základných nedostatkov;hyperammonaemia kvôli isovaleric acidaemia;hyperammonaemia kvôli methymalonic acidaemia;hyperammonaemia kvôli propiónovej acidaemia.

Európska únia - slovenčina - EMA (European Medicines Agency)

recordati rare diseases - betaine bezvodý - homocystinúria - iné alimentárny trakt a metabolizmus výrobky, - adjunctive treatment of homocystinuria, involving deficiencies or defects in:cystathionine beta-synthase (cbs);5,10-methylene-tetrahydrofolate reductase (mthfr);cobalamin cofactor metabolism (cbl). cystadane should be used as supplement to other therapies such as vitamin b6 (pyridoxine), vitamin b12 (cobalamin), folate and a specific diet.

Európska únia - slovenčina - EMA (European Medicines Agency)

recordati rare diseases - merkaptamín hydrochlorid - cystinóza - oftalmologiká - cystadrops je indikovaný na liečbu usadenín kryštálov cystínov u dospelých a detí vo veku od 2 rokov s cystinózou.

Európska únia - slovenčina - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kura - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Európska únia - slovenčina - EMA (European Medicines Agency)

novartis europharm limited - ruxolitinib (ako fosfát) - myeloproliferative disorders; polycythemia vera; graft vs host disease - antineoplastické činidlá - myelofibrosis (mf)jakavi is indicated for the treatment of disease related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. polycythaemia vera (pv)jakavi je indikovaný na liečbu dospelých pacientov s polycythaemia vera, ktorí sú odolné voči alebo netolerantné hydroxyurea. graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies (see section 5.

Európska únia - slovenčina - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - imunologická liečba - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Európska únia - slovenčina - EMA (European Medicines Agency)

hra pharma rare diseases - mitotane - adrenal cortex neoplasms - antineoplastické činidlá - symptomatická liečba pokročilého (neresekovateľného, ​​metastatického alebo relapsovaného) karcinómu nadobličiek. Účinok lysodren na non-funkčné nadobličiek kortikálnej karcinómu nie je ustanovený.

Európska únia - slovenčina - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - imunologická liečba - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Európska únia - slovenčina - EMA (European Medicines Agency)

hra pharma rare diseases - ketokonazol - cushingov syndróm - antimykotika na systémové použitie - ketokonazol hra je indikovaný na liečbu endogénneho cushingovho syndrómu u dospelých a adolescentov vo veku nad 12 rokov.

Európska únia - slovenčina - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - rekombinantnej vírus vezikulárnej stomatitídy (kmeň indiana) s odstránením obálky glykoproteín, v súlade s zair ebolavirus (kmeň kikwit 1995) povrch glykoproteín - hemorrhagic fever, ebola - vakcíny - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. použitie ervebo by mali byť v súlade s oficiálne odporúčania.